CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,939,756
- in 9 filings, $1.9M under 10b5-1 plans
Net −$1,939,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-23 | Walsh Patrick D Director | Grant or award | +6,865 | 70,302 | ||
| 2023-05-23 | Thoma Jeanne Director | Grant or award | +6,865 | 36,199 | ||
| 2023-05-23 | Pera Antonio R Director | Grant or award | +6,865 | 36,627 | ||
| 2023-05-23 | NASH DAVID Director | Grant or award | +6,865 | 38,561 | ||
| 2023-05-23 | HAUGHEY THOMAS Director | Grant or award | +6,865 | 47,116 | ||
| 2023-04-10 | CAREY STEPHEN P. SVP & CFO | Shares withheld for taxes | −4,534 | $38.50 | $175K | 173,478 |
| 2023-04-10 | Marken James G. SVP OPS & PROD DEV | Shares withheld for taxes | −2,289 | $38.50 | $88K | 131,627 |
| 2023-03-28 | Marken James G. SVP OPS & PROD DEV | Shares withheld for taxes | −524 | $38.62 | $20K | 112,206 |
| 2023-03-28 | CAREY STEPHEN P. SVP AND CFO | Shares withheld for taxes | −1,420 | $38.62 | $55K | 137,486 |
| 2023-03-23 | Marken James G. SVP OPS & PROD DEV | Shares withheld for taxes | −2,452 | $37.82 | $93K | 112,730 |
| 2023-03-23 | Lalwani Nikhil PRESIDENT & CEO | Shares withheld for taxes | −17,455 | $37.82 | $660K | 250,840 |
| 2023-03-23 | CAREY STEPHEN P. SVP AND CFO | Shares withheld for taxes | −4,224 | $37.82 | $160K | 138,906 |
| 2023-03-07 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −1,426 | $44.23 | $63K | 38,136 |
| 2023-03-07 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −476 | $44.23 | $21K | 37,660 |
| 2023-03-07 | Gutwerg Ori SVP, GENERICS | Shares withheld for taxes | −1,756 | $44.23 | $78K | 34,613 |
| 2023-03-07 | Gutwerg Ori SVP, GENERICS | Shares withheld for taxes | −586 | $44.23 | $26K | 34,027 |
| 2023-03-07 | CAREY STEPHEN P. SVP AND CFO | Shares withheld for taxes | −2,639 | $44.23 | $117K | 143,994 |
| 2023-03-07 | CAREY STEPHEN P. SVP AND CFO | Shares withheld for taxes | −864 | $44.23 | $38K | 143,130 |
| 2023-03-07 | Lalwani Nikhil PRESIDENT & CEO | Shares withheld for taxes | −9,397 | $44.23 | $416K | 272,560 |
| 2023-03-07 | Lalwani Nikhil PRESIDENT & CEO | Shares withheld for taxes | −4,265 | $44.23 | $189K | 268,295 |
Page 20 of 23 · 442 trades